The immunotherapy landscape in AML: Defining knowledge gaps toward rational combinatorial strategies
{{output}}
Immunotherapy has dramatically improved outcomes in lymphoid malignancies. In B cell cancers, CD19-directed CAR T cells and T-cell engagers have produced high remission rates and durable responses, now forming the cornerstone of treatment in many relapsed or r... ...
